Search Results - "Chamaillard, M"
-
1
A dietary flavone confers communicable protection against colitis through NLRP6 signaling independently of inflammasome activation
Published in Mucosal immunology (01-05-2018)“…Flavones represent a class of polyphenols that are found in many plant-derived food sources. Herein, we provide evidence that the anti-inflammatory and…”
Get full text
Journal Article -
2
PPARγ as a new therapeutic target in inflammatory bowel diseases
Published in Gut (01-09-2006)Get full text
Journal Article -
3
Mesenteric fat in Crohn’s disease: a pathogenetic hallmark or an innocent bystander?
Published in Gut (01-04-2007)“…[...]other mediators such as angiotensinogen, plasminogen activator inhibitor-1 (PAI-1), visfatin, adisin and vaspin are produced by adipocytes. Local…”
Get full text
Journal Article -
4
Gut microbiome and anticancer immune response: really hot Sht
Published in Cell death and differentiation (01-02-2015)“…The impact of gut microbiota in eliciting innate and adaptive immune responses beneficial for the host in the context of effective therapies against cancer has…”
Get full text
Journal Article -
5
Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation
Published in Mucosal immunology (01-07-2018)“…Upon oral infection with Toxoplasma gondii cysts (76 K strain) tachyzoites are released into the intestinal lumen and cross the epithelial barrier causing…”
Get full text
Journal Article -
6
Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis
Published in Gut (01-06-2009)“…Yersinia pseudotuberculosis causes ileitis and mesenteric lymphadenitis by mainly invading the Peyer's patches that are positioned in the terminal ileum…”
Get more information
Journal Article -
7
Correction: Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation
Published in Mucosal immunology (2019)“…The original version of this Article omitted the author Dr Mathias Chamaillard from the l’Institut de Pasteur, Lille, France. This has been corrected in both…”
Get full text
Journal Article -
8
Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation
Published in Gut (01-06-2006)“…Background and aims: Recent studies with μ opioid receptor (MOR) deficient mice support a physiological anti-inflammatory effect of MOR at the colon interface…”
Get full text
Journal Article -
9
Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn’s disease colon
Published in Gut (01-06-2003)“…Background: Crohn’s disease is one of the principal human chronic inflammatory bowel diseases. Although its aetiology is still unknown, its complex…”
Get full text
Journal Article -
10
Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop
Published in Journal of cellular physiology (01-11-2006)“…With the discovery of CARD15 as susceptibility gene for Crohn's disease (CD) a first link to a potential defect in the innate immune system was made. In this…”
Get full text
Journal Article -
11
P095 Neutralizing responsiveness to Interleukin-33 abrogat1es experimental colitis through enhanced mucosal wound healing
Published in Cytokine (Philadelphia, Pa.) (01-09-2012)“…Novel therapeutic principles are urgently needed to cure inflammatory bowel diseases (IBD) that have been intrinsically linked to a deregulated inflammatory…”
Get full text
Journal Article -
12
Debugging the intestinal microbiota in IBD
Published in Gastroentérologie clinique et biologique (01-06-2009)“…Besides its role in repelling enteropathogenic infections, the gastrointestinal tract is in intimate contact with commensal microbiota. Tremendous advances…”
Get full text
Journal Article -
13
CARD4/NOD1 is not involved in inflammatory bowel disease
Published in Gut (01-01-2003)“…Background and aims: Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are complex genetic disorders. CARD15/NOD2,…”
Get full text
Journal Article -
14
Metronidazole: alternative treatment for ocular and cutaneous rosacea in the pediatric population
Published in Journal francais d'ophtalmologie (01-12-2011)“…To assess the effectiveness and tolerance of systemic metronidazole in the treatment of childhood ocular and cutaneous rosacea. Single-center multidisciplinary…”
Get more information
Journal Article -
15
-
16
Treatment of moderate-to-severe psoriasis in adults: An expert consensus statement using a Delphi method to produce a decision-making algorithm
Published in Annales de dermatologie et de vénéréologie (01-09-2024)“…New highly effective drugs for moderate-to-severe cutaneous psoriasis are regularly marketed, and the hierarchy of treatments thus requires frequent review. A…”
Get full text
Journal Article -
17
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
Published in Immunity (Cambridge, Mass.) (21-06-2016)“…Inhibition of immune regulatory checkpoints, such as CTLA-4 and the PD-1-PD-L1 axis, is at the forefront of immunotherapy for cancers of various histological…”
Get full text
Journal Article -
18
[30] INVOLVEMENT OF NOD SIGNALLING IN HEPATOCYTE AND IMMUNE CELLS DURING HEPATITIS
Published in Journal of hepatology (2007)Get full text
Journal Article -
19
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
Published in Science (American Association for the Advancement of Science) (27-09-2019)“…We analyzed genetic data of 47,429 multiple sclerosis (MS) and 68,374 control subjects and established a reference map of the genetic architecture of MS that…”
Get full text
Journal Article -
20
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Published in Immunity (Cambridge, Mass.) (18-10-2016)“…The efficacy of the anti-cancer immunomodulatory agent cyclophosphamide (CTX) relies on intestinal bacteria. How and which relevant bacterial species are…”
Get full text
Journal Article